Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Wells Messersmith and Elizabeth Kessler.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.131 |
|
|
|
-
Kessler ER, Eckhardt SG, Pitts TM, Bradshaw-Pierce EL, O'byrant CL, Messersmith WA, Nallapreddy S, Weekes C, Spratlin J, Lieu CH, Kane MA, Eppers S, Freas E, Leong S. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. Invest New Drugs. 2016 Apr; 34(2):176-83.
Score: 0.131